SEC filings yesterday included 186 8-Ks and 9 shelf registrations, with Lisata Therapeutics leading analyst attention.
Top 3
- Lisata Therapeutics (CIK 320017) filed 8-K with 7 item codes including material acquisition (1.01), bankruptcy (2.01), and multiple regulatory sections (3.02, 5.02, 5.03), with material events nested under cost-of-living adjustment structures.
- Adial Pharmaceuticals (CIK 1513525) filed 8-K coupling material agreement closure (1.01) with regulation filing (8.01), body language suggests disclosure timing coordination.
- CID Holdco, Inc. (CIK 2033770) filed 8-K merging material agreement closure (1.01) with amendments (3.02) and regulatory filing (8.01).
Paid subscribers see 7 more flagged filings + sector signals — upgrade for $9/mo
FilingFirehose Daily · 2026-09-17